[The "DRESS" syndrome in antituberculosis drugs]

Area of Science:

• Clinical Medicine
• Pharmacovigilance
• Dermatology

Background:

• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe adverse drug reaction.
• Tuberculosis treatment often involves multiple medications with potential side effects.
• Early recognition of DRESS syndrome is crucial for patient outcomes.

Observation:

• A 27-year-old patient developed DRESS syndrome.
• The patient was undergoing treatment for pleural tuberculosis.
• Antituberculosis medications were identified as the likely cause of the DRESS syndrome.

Findings:

• DRESS syndrome induced by antituberculosis drugs is rare.
• The clinical presentation of DRESS syndrome can be severe and life-threatening.
• This case underscores the importance of considering DRESS syndrome in patients on antituberculosis therapy presenting with skin reactions.

Implications:

• Healthcare providers should maintain a high index of suspicion for DRESS syndrome in patients treated with antituberculosis drugs.
• Prompt diagnosis and withdrawal of the offending agent are critical for managing DRESS syndrome.
• Further research into the specific mechanisms and risk factors for DRESS syndrome associated with antituberculosis treatment may be warranted.